CIK 0001326732 · Accelerated filer
Xencor Inc
Sign in to watch- Ticker
- XNCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 201622502
- Phone
- 626-305-5900
- Business address
- 465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,591,617
- in 2 filings
Net −$3,591,617. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Feigal Ellen Director | Grant or award | +5,986 | 10,993 | ||
| 2024-06-13 | Feigal Ellen Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 | ||
| 2024-06-13 | GORMAN KEVIN CHARLES Director | Grant or award | +5,986 | 11,046 | ||
| 2024-06-13 | GORMAN KEVIN CHARLES Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 | ||
| 2024-06-13 | GUSTAFSON KURT A Director | Grant or award | +5,986 | 11,993 | ||
| 2024-06-13 | GUSTAFSON KURT A Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 | ||
| 2024-06-13 | Montgomery Alan Bruce Director | Grant or award | +5,986 | 10,993 | ||
| 2024-06-13 | Montgomery Alan Bruce Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 | ||
| 2024-06-13 | RANIERI RICHARD J Director | Grant or award | +5,986 | 10,993 | ||
| 2024-06-13 | RANIERI RICHARD J Director | Grant or award · Stock Option (Right to Buy) | +11,971 | 11,971 | ||
| 2024-05-02 | Valente Nancy EVP, Chief Development Officer | Sale | −4,745 | $23.58 | $112K | 55,115 |
| 2024-04-09 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Grant or award | +42,265 | 42,265 | ||
| 2024-04-09 | Cornelissen Bart Jan SR. VICE PRESIDENT & CFO | Grant or award · Stock Option (Right to Buy) | +190,194 | 190,194 | ||
| 2024-03-11 | Kuch John J SR. VICE PRESIDENT & CFO | Sale | −849 | $23.50 | $20K | 121,070 |
| 2024-03-11 | Eckert Celia SVP, GENERAL COUNSEL | Sale | −850 | $23.50 | $20K | 45,465 |
| 2024-03-11 | Desjarlais John R SR. VICE PRESIDENT & CSO | Sale | −1,280 | $23.50 | $30K | 186,433 |
| 2024-03-11 | Dahiyat Bassil I PRESIDENT & CEO | Sale | −2,741 | $23.50 | $64K | 351,894 |
| 2024-03-06 | GUSTAFSON KURT A Director | Option exercise | +15,000 | $10.73 | $161K | 20,007 |
| 2024-03-06 | GUSTAFSON KURT A Director | Sale | −14,000 | $23.18 | $324K | 6,007 |
| 2024-03-06 | GUSTAFSON KURT A Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 |
Page 8 of 11 · 211 trades